Antibacterial coated medical implants
AssigneeBoard of Regents, The University of Texas System
InventorsIssam I. Raad, Rabih O. Darouiche
Life of this patent
Estimating the term…
Loading patent…
AssigneeBoard of Regents, The University of Texas System
InventorsIssam I. Raad, Rabih O. Darouiche
Estimating the term…
An implantable medical device having long lasting resistance to staphylococcal biofilm colonization is provided. Implantable medical devices such as catheters, shunts, prosthesis, pacemakers, etc. are susceptible to colonization by biofilm adherent microorganisms, especially staphylococci. While systemic staphylococcal infections are effectively treated by many antibiotics, vancomycin being the antibiotic of choice, this same bacteria when encased in biofilm adhering to indwelling medical devices is generally resistant to antibiotic treatment. By the present invention, the combination of rifampin and minocycline or the combination of rifampin and novobiocin when coated on the surfaces of implantable medical devices unexpectedly provides superior antibacterial activity against staphylococcal biofilm colonization on the coated surface of indwelling medical devices.
An implantable medical device having one or more of its surfaces coated with an antibiotic composition comprising a combination of rifampin and minocycline, said combination coated in an amount effective to inhibit the growth of Staphylococcus.
An implantable medical device having one or more of its surfaces coated with an antibiotic composition comprising a combination of rifampin and novobiocin, said combination coated in an amount effective to inhibit the growth of Staphylococcus.
A method for inhibiting staphylococcus microbial growth on surfaces of an implantable medical device comprising:
A method for inhibiting Staphylococcus microbial growth on surfaces of an implantable medical device comprising:
Dependencies are inferred from the claim text.